Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04367311 |
| Title | Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors >= 4cm), IIA, IIB, and Select IIIA [T3N1, T4N0-1] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Nasser Hanna |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Northwestern University Feinberg School of Medicine | Recruiting | Chicago | Illinois | 60611 | United States | Details |
| Indiana University Melvin and Bren Simon Cancer Center | Recruiting | Indianapolis | Indiana | 46202 | United States | Details |
| Rutgers Cancer Institute of New Jersey | Recruiting | New Brunswick | New Jersey | 08903 | United States | Details |
| New York University Clinical Cancer Center | Recruiting | New York | New York | 10016 | United States | Details |
| Penn State Cancer Institute | Recruiting | Hershey | Pennsylvania | 17033 | United States | Details |
| University of Wisconsin | Recruiting | Madison | Wisconsin | 53705 | United States | Details |